New Orleans, USA – Royal Philips Electronics (NYSE: PHG, AEX: PHIA) today showcased its latest addition to the ClearVue ultrasound family of products at the American College of Obstetricians and Gynecologists 61st Annual Clinical Meeting in New Orleans, Louisiana, May 4- 8, 2013. The ClearVue 650 is a lightweight and cost-effective system that spans a range of applications from obstetrics and gynecology to cardiology, abdominal, vascular, breast, musculoskeletal, urology and general imaging.
Philips new ultrasound system includes cutting-edge tools such as four dimensional (4D) imaging technology called Spatio Temporal Image Correlation (STIC) that allows clinicians to quickly inform patients about any rare or complex heart abnormalities in the fetus. It produces clear, easy-to-read images that can help clinicians accurately determine gestation age, date of conception and other important information about the developing fetus, including visual confirmation of the pregnancy, a reliable image of the fetus’ well-being and heart-health, and embryonic movement a full two weeks earlier in gestation than many existing ultrasound systems.
Additionally, Philips new ultrasound system uses pulsed wave Tissue Doppler Imaging (TDI) technology that provides velocity mapping of cardiac tissue to evaluate cardiac function and wall motion. It also features Auto Face Reveal, a technology that sculpts away overlaying tissue to clearly reveal the face of the unborn baby. A published study suggests that Auto Face Reveal, and the technology powering it, may even enhance parental-fetal bonding.
“The Philips ClearVue 650 is more evidence of Philips’ continuing commitment to innovate and help clinicians improve patient outcomes and the healthcare delivery experience,” said Conrad Smits, General Manager, Ultrasound, Philips Healthcare. “It is a system that will better serve the health community with its excellent image quality and simplified workflow for clinicians across a broad range of specialties including obstetrics, gynecology and cardiology.”
Additional features and benefits available in Philips ClearVue 650 include:
- Simplified workflow; to help reduce exam time and remove the need for multiple keystrokes to access most commonly used measurements, the OB Quick Launch measurement and AFI workflow/quad view allow for easy navigation, clarity and simplicity. By removing redundant key strokes through automation, the customized SmartExam protocols enhance productivity, while the new barcode scanner speeds up patient entry and may reduce data input errors.
- Easy to use, reliable and energy-efficient; the modular design and lightweight cart is portable and easy to maneuver. ClearVue 650 runs on less power to save on energy and cooling costs.
The new Philips ClearVue 650 ultrasound system uses 3D/4D technology to enhance clinical insight and diagnostic confidence. The 3D imaging technology creates depth, whereas the 4D technology adds an element of movement.
The ClearVue 650 is the most recent addition to the ClearVue family of Philips Ultrasound products, including the 350 and 550. All systems feature the proprietary Active Array technology, which enhances maneuverability and enables superb image quality.
Visit Philips at ACOG 2013 at booth #1801 to learn more or speak with a Philips representative. For more information, please go to www.philips.com/clearvue650.
For further information, please contact:
Philips Healthcare Communications
Tel: +1 (978) 659-3748
Email: [email protected]
About Royal Philips Electronics
Royal Philips Electronics (NYSE: PHG, AEX: PHIA) is a diversified health and well-being company, focused on improving people’s lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2012 sales of EUR 24.8 billion and employs approximately 118,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming and oral healthcare.
1Pretorius D, Gattu S, Ji E, Hollenbach K, Newton R, Hull A, et al. Prexamination and postexamination assessment of parental-fetal bonding in patients undergoing 3-/4-dimensional obstetric ultrasonography. J Ultrasound Med. 2006;25:1411–1421.